SANDRIL (RESERPINE) — FDA Approval NDA010012 (LILLY)
SANDRIL (RESERPINE) — FDA Approval NDA010012 (LILLY) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SANDRIL; Active ingredients: RESERPINE; Application number: NDA010012.
| Brand name | SANDRIL |
|---|---|
| Active ingredients | RESERPINE |
| Application number | NDA010012 |
| Sponsor | LILLY |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19811022 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →